PROPULSID

Propulsid Adverse Events Reported to the FDA Over Time

How are Propulsid adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Propulsid, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Propulsid is flagged as the suspect drug causing the adverse event.

Most Common Propulsid Adverse Events Reported to the FDA

What are the most common Propulsid adverse events reported to the FDA?

Electrocardiogram Qt Prolonged	114 (13.27%)
Death	26 (3.03%)
Dehydration	14 (1.63%)
Vomiting	14 (1.63%)
Renal Failure	12 (1.4%)
Cerebrovascular Accident	11 (1.28%)
Mental Disorder	10 (1.16%)
Nausea	10 (1.16%)
Pollakiuria	10 (1.16%)
Atrioventricular Block First Degree	9 (1.05%)
Decreased Appetite	9 (1.05%)
	Show More
Drug Ineffective	9 (1.05%)
Malaise	9 (1.05%)
Aggression	8 (.93%)
Diarrhoea	8 (.93%)
Dyspnoea	8 (.93%)
Palpitations	8 (.93%)
Pneumonia	8 (.93%)
Respiratory Failure	8 (.93%)
Cardiac Disorder	7 (.81%)
Electrolyte Imbalance	7 (.81%)
Gastrointestinal Obstruction	7 (.81%)
Tachycardia	7 (.81%)
Anorexia	6 (.7%)
Cachexia	6 (.7%)
Electrocardiogram T Wave Amplitude ...	6 (.7%)
Gastrointestinal Disorder	6 (.7%)
Pleural Effusion	6 (.7%)
Post Procedural Complication	6 (.7%)
Pyrexia	6 (.7%)
Adhesion	5 (.58%)
Arrhythmia	5 (.58%)
Bundle Branch Block Right	5 (.58%)
Condition Aggravated	5 (.58%)
Gastric Cancer	5 (.58%)
Hypertension	5 (.58%)
Impaired Gastric Emptying	5 (.58%)
Intestinal Obstruction	5 (.58%)
Respiratory Disorder	5 (.58%)
Sinus Tachycardia	5 (.58%)
Spinal Fracture	5 (.58%)
Sudden Infant Death Syndrome	5 (.58%)
Surgery	5 (.58%)
Urticaria	5 (.58%)
Ventricular Tachycardia	5 (.58%)
Bradypnoea	4 (.47%)
C-reactive Protein Increased	4 (.47%)
Cholecystitis Acute	4 (.47%)
Constipation	4 (.47%)
Depression	4 (.47%)
Escherichia Infection	4 (.47%)
Hirsutism	4 (.47%)
Malignant Neoplasm Progression	4 (.47%)
Myocardial Infarction	4 (.47%)
Pneumonia Legionella	4 (.47%)
Pulmonary Oedema	4 (.47%)
Renal Failure Acute	4 (.47%)
Ruptured Cerebral Aneurysm	4 (.47%)
Ventricular Extrasystoles	4 (.47%)
Abdominal Pain Upper	3 (.35%)
Anxiety	3 (.35%)
Apnoea	3 (.35%)
Atrial Fibrillation	3 (.35%)
Blood Calcium Increased	3 (.35%)
Blood Magnesium Increased	3 (.35%)
Blood Pressure Decreased	3 (.35%)
Bronchopneumopathy	3 (.35%)
Cardiac Failure Congestive	3 (.35%)
Chest Pain	3 (.35%)
Confusional State	3 (.35%)
Cyanosis	3 (.35%)
Electrocardiogram T Wave Abnormal	3 (.35%)
Fall	3 (.35%)
Fatigue	3 (.35%)
Food Intolerance	3 (.35%)
Gastrooesophageal Reflux Disease	3 (.35%)
Headache	3 (.35%)
Heart Rate Increased	3 (.35%)
Heart Rate Irregular	3 (.35%)
Hypertrophic Cardiomyopathy	3 (.35%)
Infarction	3 (.35%)
Loss Of Consciousness	3 (.35%)
Ovarian Cyst	3 (.35%)
Pneumonia Aspiration	3 (.35%)
Porphyria	3 (.35%)
Screaming	3 (.35%)
Sepsis	3 (.35%)
Shock	3 (.35%)
Syncope	3 (.35%)
Varicose Ulceration	3 (.35%)
Abdominal Adhesions	2 (.23%)
Abdominal Pain	2 (.23%)
Acute Myocardial Infarction	2 (.23%)
Alopecia	2 (.23%)
Androgens Abnormal	2 (.23%)
Aneurysm Ruptured	2 (.23%)
Blood Follicle Stimulating Hormone ...	2 (.23%)
Blood Potassium Decreased	2 (.23%)
Blood Potassium Increased	2 (.23%)
Bradycardia	2 (.23%)
Bronchitis	2 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Propulsid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Propulsid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Propulsid

What are the most common Propulsid adverse events reported to the FDA?

Cardiac And Vascular Investigations	140 (16.3%)
Cardiac Arrhythmias	60 (6.98%)
Respiratory	41 (4.77%)
Fatal Outcomes	33 (3.84%)
Gastrointestinal Signs	33 (3.84%)
Infections - Pathogen Unspecified	28 (3.26%)
Gastrointestinal Motility And Defec...	26 (3.03%)
Electrolyte And Fluid Balance Condi...	24 (2.79%)
Appetite And General Nutritional	22 (2.56%)
Cardiac Disorder Signs	18 (2.1%)
Renal Disorders	18 (2.1%)
	Show More
Central Nervous System Vascular	17 (1.98%)
Gastrointestinal Stenosis And Obstr...	17 (1.98%)
Neurological	14 (1.63%)
Therapeutic And Nontherapeutic Effe...	14 (1.63%)
Procedural And Device Related Injur...	12 (1.4%)
Water, Electrolyte And Mineral	11 (1.28%)
Lower Respiratory Tract Disorders	10 (1.16%)
Myocardial	10 (1.16%)
Psychiatric	10 (1.16%)
Urinary Tract Signs	10 (1.16%)
Skin Appendage Conditions	9 (1.05%)
Bacterial Infectious	8 (.93%)
Personality Disorders	8 (.93%)
Therapeutic Procedures And Supporti...	8 (.93%)
Pleural	7 (.81%)
Body Temperature Conditions	6 (.7%)
Coronary Artery	6 (.7%)
Gallbladder	6 (.7%)
Gastrointestinal Conditions	6 (.7%)
Muscle	6 (.7%)
Viral Infectious	6 (.7%)
Angiedema And Urticaria	5 (.58%)
Bone And Joint Injuries	5 (.58%)
Gastrointestinal Inflammatory Condi...	5 (.58%)
Gastrointestinal Neoplasms Malignan...	5 (.58%)
Hepatic And Hepatobiliary	5 (.58%)
Injuries	5 (.58%)
Peritoneal And Retroperitoneal Cond...	5 (.58%)
Vascular Hypertensive	5 (.58%)
Decreased And Nonspecific Blood Pre...	4 (.47%)
Depressed Mood Disorders	4 (.47%)
Endocrine Investigations	4 (.47%)
Headaches	4 (.47%)
Heart Failures	4 (.47%)
Mental Impairment	4 (.47%)
Metabolic, Nutritional And Blood Ga...	4 (.47%)
Miscellaneous And Site Unspecified ...	4 (.47%)
Protein And Chemistry Analyses	4 (.47%)
Anxiety Disorders	3 (.35%)
Arteriosclerosis, Stenosis, Vascula...	3 (.35%)
Cardiac Valve	3 (.35%)
Communication Disorders	3 (.35%)
Deliria	3 (.35%)
Encephalopathies	3 (.35%)
Food Intolerance Syndromes	3 (.35%)
Gastrointestinal Therapeutic Proced...	3 (.35%)
Gastrointestinal Ulceration And Per...	3 (.35%)
Hematology Investigations	3 (.35%)
Metabolic And Nutritional Disorders...	3 (.35%)
Ovarian And Fallopian Tube	3 (.35%)
Venous Varices	3 (.35%)
Acid-base	2 (.23%)
Ancillary Infectious Topics	2 (.23%)
Aneurysms And Artery Dissections	2 (.23%)
Bone Disorders	2 (.23%)
Chemical Injury And Poisoning	2 (.23%)
Fungal Infectious	2 (.23%)
Gastrointestinal	2 (.23%)
Gastrointestinal Hemorrhages	2 (.23%)
Gastrointestinal Tract Disorders Co...	2 (.23%)
Glucose Metabolism Disorders	2 (.23%)
Inner Ear And Viiith Cranial Nerve	2 (.23%)
Legal Issues	2 (.23%)
Medication Errors	2 (.23%)
Pericardial	2 (.23%)
Renal And Urinary Tract Investigati...	2 (.23%)
Seizures	2 (.23%)
Vascular	2 (.23%)
Abdominal Hernias And Other Abdomin...	1 (.12%)
Abortions And Stillbirth	1 (.12%)
Allergic Conditions	1 (.12%)
Anal And Rectal Conditions	1 (.12%)
Anemias Nonhemolytic And Marrow Dep...	1 (.12%)
Breast Neoplasms Malignant And Unsp...	1 (.12%)
Cardiac And Vascular Disorders Cong...	1 (.12%)
Diabetic Complications	1 (.12%)
Epidermal And Dermal Conditions	1 (.12%)
Hematological And Lymphoid Tissue T...	1 (.12%)
Hepatobiliary	1 (.12%)
Hepatobiliary Therapeutic Procedure...	1 (.12%)
Immune	1 (.12%)
Immunodeficiency Syndromes	1 (.12%)
Lifestyle Issues	1 (.12%)
Movement Disorders	1 (.12%)
Musculoskeletal And Connective Tiss...	1 (.12%)
Musculoskeletal And Connective Tiss...	1 (.12%)
Neonatal Respiratory	1 (.12%)
Nephropathies	1 (.12%)
Neuromuscular	1 (.12%)
Ocular Infections, Irritations And ...	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Propulsid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Propulsid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.